期刊文献+

剂量体积直方图参数对放射性肺炎的工作特征曲线预测分析 被引量:2

Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve
原文传递
导出
摘要 目的应用受试者工作特征曲线(ROC)对剂量体积直方图参数(DVH)预测放射性肺炎(RP)进行分析,探究DVH参数预测RP的准确性(ACC)、敏感性(SEN)和特异性(SPE)。方法收集118例接受三维适形调强放疗和化疗的非小细胞肺癌患者资料,回顾分析三维放疗计划系统中双肺V5、V10、V13、V20、V30(Vx为接受≥xGy的相对肺体积)和平均肺剂量(MLD)与治疗后出现≥2级RP(CTCAE3.0)的相关性。对上述DVH参数应用ROC曲线进行回顾性分析,确定预测RP的ACC、SEN和SPE。结果单因素分析显示,双肺V5、V10、V13、V20和MLD均与RP发生显著相关(x2=4.786、5.771、6.366、7.367、6.945,P〈0.05);双肺V30、患者因素(年龄、性别、KPS评分、肿瘤位置、病理类型)和治疗因素(放疗总剂量、照射技术、化疗方案、化疗时机)与RP的发生风险无显著相关性。多因素分析显示双肺‰与RP发生风险相关(x2=10.96,OR=4.16,95%CI1.40~12.36,P〈0.05),与其他DVH参数具有显著共线性(r=0.767—0.902,P〈0.05)。ROC曲线证实双肺屹。能够预测RP的发生(Z=2.038,P〈0.05),其预测的ACC、SEN和SPE分别为0.645(95%C10.498—0.793),0.650(95%C10.408—0.864)和0.674(95%C10.571—0.765),其阳性预测值仅为28.9%。结论双肺K。与RP的发生风险相关,能够预测RP的发生,但是预测能力有限。 Objective To assess the accuracy (ACC), sensitivity (SEN), and specificity (SPE) of dose-volume histogram (DVH) parameters in predicting the radiation pneumonitis (RP) using receiver operating characteristic (ROC) curve. Methods Complete clinical data of 118 non-small cell lung cancer patients treated with three-dimensional conformal and intensity-modulated radiotherapy plus chemotherapy were included. Chi-square and logistic regression were retrospectively applied to analyze the correlations between DVH parameters [ relative lung volume received ≥5 Gy ( V5 ), 10 Gy ( V10 ), 13 Gy ( V13 ), 20 Gy ( V20 ) and 30 Gy ( V30 ) and mean lung dose (MLD) ] and grade 2 ( and above) RP defined by the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0. ROC curve was adopted to investigate the predictive ACC, SEN and SPE of potential DVH parameters associated with RP. Results Total lungs V5 , Vt0, V13, V20 and MLD were all correlated to the development of RP (X2 = 4. 786,5. 771,6. 366,7. 367 and 6. 945 ,P 〈 0.05 ) according to univariate analysis. However, total lungs V30, patient characteristics ( age, sex, KPS, tumor location, pathology ) and treatment factors (prescription dose, radiotherapy technique, chemotherapy method and timing) were not contributors to RP. Logistic regression showed that V20 of both lungs remains tight by associated with RP (X2 = 10. 96, OR = 4. 16, 95% CI 1.40 ~ 12. 36,P 〈 0. 05), although significant colinearity was found between V20 and other DVH parameters ( r = 0. 767 - 0. 902,P 〈 0. 05). ROC curve confirmed that V20 of both lungs could act as a predictor for RP ( Z = 2. 038,P 〈 0. 05). The predictive ACC, SEN, and SPE were 0. 645 (95% CI0.498 - 0.793), 0.650 (95% CI0.408 - 0.864), and 0.674 (95% CI0.571 - 0.765), respectively. However, the positive predictive value was only 28.9%. Conclusions V20 of both lungs was correlated to the development of RP. It could act
机构地区 山东省肿瘤医院
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2012年第5期505-508,共4页 Chinese Journal of Radiological Medicine and Protection
关键词 非小细胞肺癌 剂量体积直方图 放射性肺炎 受试者工作特征曲线 Non-small cell lung cancer Dose-volume histogram Radiation pneumonitis Receiver operating characteristic curve
  • 相关文献

参考文献17

  • 1Graham MV, Purdy JA, Emami B, et a1. Clinical dose-volume histogram analysis for pneumonitis after 3 D treatment for non small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys, 1999, 45 (2) :323-329. 被引量:1
  • 2Claude L, Perol D, Ginestet C, et a1. A prospective study on radiation pneumonitis following conformal radiation therapy in non-smaIl-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol, 2004, 71 ( 2) : 175- 181. 被引量:1
  • 3Yorke ED, Jackson A, Rosenzweig KE, et a1. Correlation of dosimetric factors and radiation pneumonitis for non-smaIl-cell lung cancer patients in a. recently completed dose escalation study. Int J Radiat Oncol Biol Phys, 2005, 63 (3 ) : 672 - 682. 被引量:1
  • 4Allen AM, Czerminska M, Jilnne PA, et a1. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol BioI Phys , 2006, 65 (3) :640- 645. 被引量:1
  • 5Wang S, Liao Z, Wei X, et a1. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis ( TRP) in patients with non-smaIl-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3 D-CRT ). Int J Radiat Oncol BioI Phys, 2006, 66 (5) : 1399-1407. 被引量:1
  • 6Schallenkamp JM, Miller RC, Brinkmann DH, et a1. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol BioI Phys, 2007 , 67 (2) : 410-416. 被引量:1
  • 7Trotti A , Colevas AD , Setser A , et al, CTCAE v3. 0 : development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol, 2003, 13 ( 3 ) : 176-181. 被引量:1
  • 8Dang J, Li G, Lu X, et a1. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol, 2010, 136 ( 8 ) : 1169-1178. 被引量:1
  • 9Jin H, Tucker SL, Liu HH, et a1. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol, 2009, 91 (3) :427-432. 被引量:1
  • 10Kocak Z, Borst GR, Zeng J, et a1. Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol BioI Phys, 2007, 67 ( 1 ) : 178-186. 被引量:1

同被引文献10

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部